Clinical Trials Browser

Phase 2 × Unknown × peginterferon alfa-2b × Clear all

NCT00746746 2011-01-13

A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma

Phase 2 Unknown

Melanoma